Stephan Eisenmann

Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

Marius M. Hoeper, Krit Dwivedi, Christine Pausch et al. · The Lancet Respiratory Medicine · 2022 · 172 citations · Full text

Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP)

Martin Faehling, Christian Schumann, Petros Christopoulos et al. · Lung Cancer · 2020 · 72 citations

Radiation Medicine, Medicine, Real-world Data +9

Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

Stephan Rosenkranz, Christine Pausch, Gerry Coghlan et al. · The Journal of Heart and Lung Transplantation · 2022 · 66 citations · Full text

Hypertension, Pulmonary Arterial Hypertension, Cardiovascular Epidemiology +11

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

Ahmet Uluer, Gordon MacGregor, Pilar Azevedo et al. · The Lancet Respiratory Medicine · 2023 · 61 citations · Full text

Medicine, Phase 2

A Prospective, Randomized Trial for the Comparison of 19-G and 22-G Endobronchial Ultrasound-Guided Transbronchial Aspiration Needles; Introducing a Novel End Point of Sample Weight Corrected for Blood Content

Celina Wolters, Kaid Darwiche, Daniel Franzen et al. · Clinical Lung Cancer · 2019 · 42 citations

Blood Content, Medical Ultrasound, Radiology +9